The Regulars

Pharmalot By Ed Silverman

Many Medicare Part D beneficiaries don’t fill prescriptions for high-priced medicines

Pharmalot By Ed Silverman

Pharmalittle: Most Americans would get a second booster shot; FDA pulls Glaxo Covid treatment

Pharmalot By Ed Silverman

STAT-Harris Poll: Most Americans would get a Covid-19 booster shot if recommended

Pharmalot By Ed Silverman

Colombian government faces calls to issue compulsory license for Pfizer’s Covid-19 pill

Pharmalot By Ed Silverman

Pharmalittle: Bluebird axes nearly one-third of its employees; Senate committee probes Merck’s tax practices

Pharmalot By Ed Silverman

Wyden wants details on Merck’s U.S. taxes as part of expanding probe into pharma practices

Pharmalot By Ed Silverman

Medicare Part D and its beneficiaries could have saved millions if more biosimilars were accessible

Pharmalot By Ed Silverman

Pharmalittle: Novartis reorganizes and hopes to save $1 billion; industry-backed antibiotic fund makes first investments

Pharmalot By Ed Silverman

Pharma’s ambitious new antibiotic venture fund makes its first investments

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Califf admits Alzheimer’s drug controversy has hurt expert trust in FDA; House passes bill to lower insulin costs

Pharmalot By Ed Silverman

In the wake of Covid, a World Health Assembly proposal would bolster quality of clinical trials

Pharmalot By Elizabeth Cooney

Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex looks to advance experimental pain drug

Pharmalot By Ed Silverman

Pharma companies face shareholder proposals to widen access to medicines, rework business practices

Pharmalot By Ed Silverman

CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis

Pharmalot By Ed Silverman

Pharmalittle: Roche immunotherapy fails its first test; key U.S. senators move closer to bill to cap insulin prices

Pharmalot By Ed Silverman

HHS seeks to penalize another drugmaker amid legal clash over drug discount program

Pharmalot By Ed Silverman

Inflation caused ‘unprecedented’ drops in net pharmaceutical prices, analysis finds

Pharmalot By Ed Silverman

Pharmalittle: Pfizer employees balk at returning overpayments; Biogen stops work on another ALS drug

Pharmalot By Ed Silverman

Pharmalittle: Pharma showers cash on a rising U.S. Senate star; FDA restricts use of a Glaxo Covid treatment

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Pharma hunts for a cure for long Covid; Texas AG deepens puberty-blocker probe into AbbVie and Endo